• Facebook
  • X
  • Events
  • News
  • Donate
Search
Hit enter to search or ESC to close
New Jersey Alliance for Clinical and Translational Science New Jersey Alliance for Clinical and Translational Science
  • Home
  • About
    • Mission
    • Membership
    • Affiliated Institutions
    • NJ ACTS Leadership
    • Cite the CTSA and Publications
    • CTSA Resources
    • Elements
  • Community
    • Our Services
    • Community Leadership
    • Volunteering for a Clinical Trial FAQs
    • Find a Clinical Trial
    • Partnership & Innovation Funding Opportunities
    • COVID-19 Resources
  • Investigator Resources
    • Funding Opportunities
    • Biostatistics, Epidemiology, Research Design (BERD)
    • Informatics Services
    • Regulatory Knowledge & Support
    • Special Populations in Research
    • Team Science
    • Genetically informed Research, Education, And Treatment
    • Biomarkers
    • ResearchMatch (RM)
    • Dissemination & Implementation Workgroup
    • COVID-19
    • Additional Resources
  • Education & Training
    • Workforce Development
    • R25 Clinical Research Experiential Summer Training (CREST)
    • Badges
    • Seminars, Workshops, Media Library
    • Learning Health System – STAR
    • Promoting STEM in High School and Earlier
    • Undergraduate Education and Training
    • Beyond Traditional Graduate Courses
    • NJ ACTS Collaborative Graduate Programs
  • K12 & T32
    • K12 Mentored Career Development Awards
    • T32 Predoctoral Training Awards
  • Clinical Trials Office
    • About
    • OnCore
    • Solutions
    • Services
    • I want to start a clinical trial
    • Resources
  • Contact Us
    • NJ ACTS Newsletter
Select Page

Clinical Trial Tests Drug for COVID-19 ‘CYTOKINE STORMS’

by William Jester | May 9, 2020 | Community, Covid, News

Researchers will give the drug, EDP1815, developed by Evelo Biosciences Inc., to newly hospitalized COVID-19 patients at Robert Wood Johnson University Hospital in New Jersey to determine if it can regulate the onslaught of cytokine proteins—which cause the immune...

How the Coronavirus Pandemic Can Exacerbate Symptoms of Obsessive-Compulsive Disorder

by William Jester | May 8, 2020 | Community, Covid, News

By now, you (hopefully!) can recite ways to prevent the spread of coronavirus in your sleep: wash your hands regularly with soap and water for at least 20 seconds, don’t touch your face, and sanitize commonly used surfaces often, among others. With the constant...

Rutgers Public Health Research Institute is looking for volunteers to participate in a one-time COVID-19 blood draw study.

by William Jester | May 8, 2020 | Community, Covid, News

Have you been diagnosed with COVID-19?  Do you want to help during this pandemic?  Rutgers Public Health Research Institute is looking for volunteers to participate in a one-time COVID-19 blood draw study.  For more information call 973-558-1339....

Evelo Biosciences, Rutgers University, and Robert Wood Johnson University Hospital Announce Submission of IND for a Phase 2 Study of EDP1815 in COVID-19 Patients

by William Jester | May 8, 2020 | Community, Covid, News

Evelo Biosciences, Inc. (Nasdaq:EVLO), Rutgers University, and Robert Wood Johnson University Hospital today announced the submission of an Investigational New Drug (IND) application for an Evelo-sponsored Phase 2 clinical study evaluating the safety and efficacy of...

RBHS Researchers Launch Study of COVID-19 Transmission and Severity

by William Jester | May 6, 2020 | Community, Covid, News

To combat the spread of COVID-19, researchers at Rutgers Biomedical and Health Sciences (RBHS) are conducting a six-month study with 750 participants who work at Rutgers and affiliated hospitals to learn more about the incidence, transmission, and severity of the...
« Older Entries
Next Entries »

Recent Posts

  • NJ ACTS Special Populations Seminar 9/29 – Register Now
  • NIH Fellowship Writing Group: Call for Applications – Sign Up by 8/25
  • Join The National Clinical Cohort Collaborative (N3C) Community Forum on 7/30
  • NIH Fellowship Writing Group: Call for Applications – Sign Up by 8/25
  • Rutgers Students Showcase AI-Driven Research Success Through NJ ACTS Summer Research Program

Archives

  • 2026
    • August
    • July
    • June
    • May
    • April
    • March
    • February
    • January
  • 2025
    • December
    • November
    • October
    • September
    • August
    • July
    • June
    • May
    • April
    • March
    • February
    • January
  • 2024
    • December
    • November
    • October
    • September
    • August
    • July
    • June
    • May
    • April
    • March
    • February
    • January
  • 2023
    • December
    • November
    • October
    • September
    • August
    • July
    • June
    • May
    • April
    • March
    • February
    • January
  • 2022
    • December
    • November
    • October
    • September
    • August
    • July
    • June
    • May
    • April
    • March
    • February
    • January
  • 2021
    • December
    • November
    • October
    • September
    • August
    • July
    • June
    • May
    • April
    • March
    • February
    • January
  • 2020
    • December
    • November
    • October
    • September
    • August
    • July
    • June
    • May
    • April
    • March
    • February
    • January
  • 2019
    • December
    • November
    • October
    • September
    • August
    • July
    • June
    • May
    • April
    • March
    • February
    • January
  • 2018
    • December

Categories

  • Community (2,501)
  • Covid (1,001)
  • CTO Events (6)
  • News (3,175)
  • Pilots (21)
Rutgers R Block logo graphic

THIS SITE

About

Membership

Community

Investigator Resources

Education & Training

News

Events

Contact

CONTACT US

New Jersey Alliance For Clinical and Translational Science (NJ ACTS)

 


  • Facebook

  • Twitter

  • YouTube

  • LinkedIn

© 2019, New Jersey Alliance for Clinical and Translational Science (NJ ACTS). All rights reserved.| Privacy Policy

Rutgers, The State University of New Jersey, is an equal access/equal opportunity institution. Individuals with disabilities are encouraged to direct suggestions, comments, or complaints concerning any accessibility issues with Rutgers web sites to accessibility@rutgers.edu or complete the Report Accessibility Barrier or Provide Feedback Form.